首页> 外文期刊>Diabetes >Partial Reversibility of Hypothalamic Dysfunction and Changes in Brain Activity After Body Mass Reduction in Obese Subjects
【24h】

Partial Reversibility of Hypothalamic Dysfunction and Changes in Brain Activity After Body Mass Reduction in Obese Subjects

机译:肥胖患者体重减轻后下丘脑功能障碍的部分可逆性和脑活动的变化

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVE—Inflammation and dysfunction of the hypothala-mus are common features of experimental obesity. However, it is unknown whether obesity and massive loss of body mass can modify the immunologic status or the functional activity of the human brain. Therefore, the aim of this study was to determine the effect of body mass reduction on brain functionality. RESEARCH DESIGN AND METHODS—In humans, changes in hypothalamic activity after a meal or glucose intake can be detected by functional magnetic resonance imaging (fMRI). Distinct fMRI analytic methods have been developed to explore changes in the brain's activity in several physiologic and pathologic conditions. We used two analytic methods of fMRI to explore the changes in the brain activity after body mass reduction. RESULTS—Obese patients present distinct functional activity patterns in selected brain regions compared with lean subjects. On massive loss of body mass, after bariatric surgery, increases in the cerebrospinal fluid (CSF) concentrations of interleukin (IL)-10 and IL-6 are accompanied by changes in fMRI patterns, particularly in the hypothalamus. CONCLUSIONS—Massive reduction of body mass promotes a partial reversal of hypothalamic dysfunction and increases anti-inflammatory activity in the CSF. Diabetes 60:1699-1704, 2011
机译:目的—下丘脑的炎症和功能障碍是实验性肥胖症的常见特征。但是,肥胖和大量体重减轻是否会改变人脑的免疫状态或功能活动尚不清楚。因此,这项研究的目的是确定减少体重对大脑功能的影响。研究设计和方法—在人类中,进餐或摄入葡萄糖后下丘脑活动的变化可以通过功能磁共振成像(fMRI)进行检测。已经开发出不同的功能磁共振成像分析方法来探索几种生理和病理条件下大脑活动的变化。我们使用功能磁共振成像的两种分析方法来探索减少体重后大脑活动的变化。结果—与瘦弱的受试者相比,肥胖患者在选定的大脑区域表现出明显的功能活动模式。减肥手术后,体重大量减少时,脑脊液(CSF)中白介素(IL)-10和IL-6的浓度升高,同时伴有功能磁共振成像模式的改变,尤其是下丘脑。结论—体重的大量减少促进了下丘脑功能障碍的部分逆转并增加了CSF的抗炎活性。糖尿病60:1699-1704,2011年

著录项

  • 来源
    《Diabetes》 |2011年第6期|p.1699-1704|共6页
  • 作者单位

    Laboratory of Cell Signaling, University of Campinas, Campinas,Brazil;

    Department of Neurology, University of Campinas, Campinas,Brazil;

    Laboratory of Cell Signaling, University of Campinas, Campinas,Brazil,Faculty of Applied Sciences, University of Campinas, Campi-nas, Brazil;

    Department of Neurology, University of Campinas, Campinas,Brazil;

    Department of Anesthesiology, University of Campinas,Campinas, Brazil;

    Department of Clinical Pathology, University ofCampinas, Campinas, Brazil;

    Department of Surgery, Universityof Campinas, Campinas, Brazil;

    Department of Surgery, Universityof Campinas, Campinas, Brazil;

    Laboratory of Investigation inMetabolism and Diabetes, University of Campinas, Campinas, Brazil;

    Laboratory of Cell Signaling, University of Campinas, Campinas,Brazil;

    Department of Neurology, University of Campinas, Campinas,Brazil;

    Laboratory of Cell Signaling, University of Campinas, Campinas,Brazil;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:46:34

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号